EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiotoxicity in Elderly Breast Cancer Patients

Kalliopi Keramida iD, Anastasia Constantinidou iD, Dorothea Tsekoura iD, Effrosyni Kampouroglou iD, Chrissovalantis Aidarinis, Emmanouil Saloustros, Georgia Karanasiou iD, Gaia Giulia Angela Sacco, Erika Matos iD, Andri Papakonstantinou iD, Manolis Tsiknakis iD, Cameron Brown iD und 6 weitere

Cancers · 30.06.2025 · 17 (13) · 2198

DOI: 10.3390/cancers17132198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.06.2025. Verfasst von Kalliopi Keramida und 17 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Athens University Hospital Attikon, 11527 Athens, Greec…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study has received funding from the European Union's (EU) Horizon 2020 research and innovation program under grant agreement No 945175. The action name is:…, European Union’s (EU) Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiotoxicity is a leading cause of mortality in the growing populations of elderly breast cancer (BC) patients. Breast cancer treatment in the elderly is highly challenging due to its heterogeneous nature and the lack of specific evidence, as this population is usually underrepresented in randomized clinical trials. Decision making requires a comprehensive approach, considering the type and stage of BC, the patient’s overall health status, life expectancy, geriatric and frailty assessment, the risk of cancer recurrence, comorbidities, cardiotoxicity risk, and the patient’s preferences. The cardiotoxic effects of BC treatments cover the whole spectrum of cardiovascular diseases: heart failure, hypertension, arrhythmias, and myocardial ischemia. Cardiotoxicity risk in these patients is defined by several factors: anticancer therapies, polypharmacy, established cardiovascular disease, comorbidities, frailty, cellular senescence, hormonal changes, and genetic predisposition. Preventive oncological and cardio-oncological strategies, as well as patients’ education, are critical for improved outcomes. Prospective clinical trials in this population are urgently needed.

Schlagwörter

Stichwörter der Autor:innen

breast cancercardiotoxicityelderlyfrailtyheart failure

Autor:innen und Institutionen

  • 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Athens University Hospital Attikon, 11527 Athens, Greece.
  • Cardiology Department, General Anti-Cancer Oncological Hospital, Agios Savvas, 11522 Athens, Greece.
  • Department of Medical Oncology, Bank of Cyprus Oncology Centre, 32 Acropoleos Avenue, Nicosia 2006, Cyprus.
  • School of Medicine, University of Cyprus, Panepistimiou 1, Nicosia 2408, Cyprus.
  • 2nd Department of Surgery, Aretaieio University Hospital, National and Kapodistrian University of Athens, 76 Vas. Sofias Av., 11528 Athens, Greece.
  • Department of Oncology, University Hospital of Larissa, 41110 Larissa, Greece.

ORCID-Profile: Kalliopi Keramida, Anastasia Constantinidou, Dorothea Tsekoura, Effrosyni Kampouroglou, Georgia Karanasiou, Erika Matos, Andri Papakonstantinou, Manolis Tsiknakis, Cameron Brown, Athos Antoniades, Daniela Cardinale, Dimitrios Fotiadis, Gerasimos Filippatos

Förderung

  • The study has received funding from the European Union's (EU) Horizon 2020 research and innovation program under grant agreement No 945175. The action name is:…
  • European Union’s (EU) Horizon 2020 research and innovation program

Zitieren

APA

Keramida, K., Constantinidou, A., Tsekoura, D., Kampouroglou, E., Aidarinis, C., Saloustros, E., Karanasiou, G., Sacco, G. G. A., Matos, E., Papakonstantinou, A., Tsiknakis, M., Brown, C., Antoniades, A., Cipolla, C., Cardinale, D., Fotiadis, D., Filippatos, G., & Investigators Cardiocare Consortium (2025). Cardiotoxicity in Elderly Breast Cancer Patients. Cancers, 17(13), 2198. https://doi.org/10.3390/cancers17132198

Vancouver

Keramida K, Constantinidou A, Tsekoura D, Kampouroglou E, Aidarinis C, Saloustros E, et al. Cardiotoxicity in Elderly Breast Cancer Patients. Cancers. 2025;17(13):2198. doi:10.3390/cancers17132198

BibTeX
@article{Keramida2025,
  author = {Keramida, Kalliopi and Constantinidou, Anastasia and Tsekoura, Dorothea and Kampouroglou, Effrosyni and Aidarinis, Chrissovalantis and Saloustros, Emmanouil and Karanasiou, Georgia and Sacco, Gaia Giulia Angela and Matos, Erika and Papakonstantinou, Andri and Tsiknakis, Manolis and Brown, Cameron and Antoniades, Athos and Cipolla, Carlo and Cardinale, Daniela and Fotiadis, Dimitrios and Filippatos, Gerasimos and Investigators Cardiocare Consortium},
  title = {Cardiotoxicity in Elderly Breast Cancer Patients},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {13},
  pages = {2198},
  doi = {10.3390/cancers17132198}
}
Kostenlos starten →